LONDON, England, Jan. 28 (TNSres) -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Jan. 27, 2025:

* * *

If approved, the new presentation will offer a convenient administration option to healthcare professionals

Globally, up to 1 in 3 adults will develop shingles in their lifetime1,2,3,4

Over 25 million people in Europe have received GSK's shingles vaccine since 20185

* * *

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products